Red X iconGreen tick iconYellow tick icon

Chris Florkowski



Associate Professor Chris Florkowski is the convener of Clinical Chemistry for the Pathology Vertical Module.

He is also a Clinical Biochemist at the Canterbury Health Laboratories.


Li, B., Elston, M., Moore, J., du Toit, S., Potter, H., Ranasinghe, I., & Florkowski, C. (2024). Discordant thyroid function tests: Beware of albumin variants. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1588), 90-93. Retrieved from

Hughes, R. C. E., Phillips, I., Florkowski, C. M., & Gullam, J. (2023). The predictive value of the sFlt-1/PlGF ratio in suspected preeclampsia in a New Zealand population: A prospective cohort study. Australian & New Zealand Journal of Obstetrics & Gynaecology, 63, 34-41. doi: 10.1111/ajo.13549

Li, B., Falvey, J., Pike, L., Sies, C., Chapman, P., & Florkowski, C. (2022). A case of macroenzyme aspartate aminotransferase (macro-AST) in a patient with seronegative rheumatoid arthritis. New Zealand Medical Journal, 135(1558), 106-109. Retrieved from

Hughes, R., Phillips, I., Florkowski, C., & Gullam, J. (2022). Diabetes in pregnancy: Using the Sflt-1/PLGF ratio to predict preeclampsia. Proceedings of the 45th New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting. (pp. 18). Retrieved from

Moore, J. A., Li, B. V., Wang, D., Chan, B., King, R. I., & Florkowski, C. M. (2022). Hƅ Westport [β121 (GH4) Glu>Asp; HBB:c.366A>C]: A novel β-globin variant interfering with HƅA1c measurement. Clinical Biochemistry, 107, 62-66. doi: 10.1016/j.clinbiochem.2022.05.003

Back to top